Image of Risk of cutaneous adverse reactions associated with allopurinol or febuxostat in real‐world patients: A nationwide study

LITERATURE

Risk of cutaneous adverse reactions associated with allopurinol or febuxostat in real‐world patients: A nationwide study


Allopurinol carries a well‐known risk of cutaneous adverse reactions (CARs). Although febuxostat, a xanthine‐oxidase inhibitor with different chemical structure, has been considered an alternative to allopurinol, post‐marketing case reports of life‐ threatening febuxostat‐related CARs have been reported. We aimed to compare the risk of CARs between allopurinol and febuxostat in real‐world settings and to assess the impact of the market entry of febuxostat on allopurinol use and associated CARs.


Availability

Festaric-011Available

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
Int J Clin Pract. 2019;73:e13316
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous